Evidence map›Paper›PMID 34118711›Full record

ArticleJournal of substance abuse treatment2021

Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorder.

Ariel Ludwig, Laura B Monico, Jan Gryczynski, Elizabeth Lertch, Robert P Schwartz, Marc Fishman, Ross Dionne, Shannon Gwin Mitchell

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ariel LudwigFriends Research Institute, Inc., 1040 Park Avenue, Suite 103, Baltimore, MD 21201, United States of America. Electronic address: aludwig@friendsresearch.org.
Laura B MonicoFriends Research Institute, Inc., 1040 Park Avenue, Suite 103, Baltimore, MD 21201, United States of America.
Jan GryczynskiFriends Research Institute, Inc., 1040 Park Avenue, Suite 103, Baltimore, MD 21201, United States of America.
Elizabeth LertchFriends Research Institute, Inc., 1040 Park Avenue, Suite 103, Baltimore, MD 21201, United States of America. Electronic address: elertch@friendsresearch.org.
Robert P SchwartzFriends Research Institute, Inc., 1040 Park Avenue, Suite 103, Baltimore, MD 21201, United States of America.
Marc FishmanMountain Manor Treatment Center, 3800 Frederick Ave, Baltimore, MD 21229, United States of America.
Ross DionnePacifica Graduate Institute, 249 Lambert Rd., Carpinteria, CA 93013, United States of America.
Shannon Gwin MitchellFriends Research Institute, Inc., 1040 Park Avenue, Suite 103, Baltimore, MD 21201, United States of America.
Friends Research Institute · USPacifica Graduate Institute · US

Funding

Health Services Research: Extended Release Naltrexone for Opioid-Dependent YouthR01DA033391 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI MITCHELL, SHANNON GWIN · 2013 to 2018
$3.3M
NIDA NIH HHS R01 DA033391
6 · The paper itself

Abstract

Opioid use disorder (OUD) among adolescents and young adults (youth) is associated with drug use and sexual HIV-related risk behaviors and opioid overdose. This mixed methods analysis assesses risk behaviors among a sample of 15-21-year-olds (N = 288) who were being treated for OUD in a residential drug treatment program in Baltimore, Maryland. Participants were enrolled in a parent study in which they received either extended-release naltrexone (XR-NTX) or Treatment as Usual (TAU), consisting of outpatient counseling with or without buprenorphine, prior to discharge. At baseline, participants were administered the HIV-Risk Assessment Battery (RAB), and clinical intake records were reviewed to determine participants' history of sexual, physical, or other abuse, as well as parental and partner substance use. A sub-sample of study participants completed semi-structured qualitative interviews (N = 35) at baseline, three-, and six-month follow-up periods. This analysis identified gender (e.g., female IRR = 1.63, CI 1.10-2.42, p = .014), the experience of dependence (e.g., previous detoxification IRR = 1.08, CI 1.01-1.15, p = .033) and withdrawal (e.g., severe withdrawal symptoms IRR = 1.41, CI 1.08-1.84, p = .012), and the role of relationships (e.g., using with partner IRR = 2.45, CI 1.15-5.22, p = .021) as influencing high-risk substance use behaviors. Similarly, high-risk sex was influenced by gender (e.g., female IRR = 1.43, CI 1.28-1.59, p < .001), and the role of relationships (e.g., using with partner IRR = 0.78, CI 0.62-0.98, p = .036). These are key targets for future prevention, treatment, and intervention.

Indexed as

HIV InfectionsOpioid-Related DisordersAdolescentDelayed-Action PreparationsFemaleHumansNaltrexoneNarcotic AntagonistsRisk-TakingYoung AdultDelayed-Action PreparationsNaltrexoneNarcotic AntagonistsHIV risk behaviorMixed methodsOpioid use disorderQualitative

Identifiers

PMID34118711
PMCPMC8548069
OpenAlexW3161401375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.